Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Benitec Biopharma Inc. entered into Securities Purchase Agreement with institutional accredited investors valued at aggregate gross proceeds of approximately $40.0 million for 5,749,152 shares at $4.80 per share and (effective 2024-04-17).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- institutional accredited investors
- Value
- aggregate gross proceeds of approximately $40.0 million for 5,749,152 shares at $4.80 per share and
- Effective
- 2024-04-17
Exact text from the filing
On April 17, 2024, Benitec Biopharma Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional accredited investors named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the “Private Placement”), (i) an aggregate of 5,749,152 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $4.80 per share and (ii) in lieu of shares of Common Stock to certain Purchasers, pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 2,584,239 shares of Common Stock (the “Warrant Shares”) at a purchase price of $4.7999 per Pre-Funded Warrant (representing the $4.80 per Share purchase price less the exercise price of $0.0001 per Pre-Funded Warrant Share).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Benitec Biopharma Inc. entered into Registration Rights Agreement with the Purchasers valued at Company agrees to file a registration statement covering resale of Registrable Securities by 30th ca (effective 2024-04-22).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the Purchasers
- Value
- Company agrees to file a registration statement covering resale of Registrable Securities by 30th ca
- Effective
- 2024-04-22
Exact text from the filing
In connection with the closing of the Private Placement, on the Closing Date, the Company will enter into a registration rights agreement (the “Registration Rights Agreement”) with the Purchasers, pursuant to which the Company will agree to register for resale the Shares and the Warrant Shares held by the Purchasers (the “Registrable Securities”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.85
Benitec Biopharma Inc. entered into Voting Commitment Agreement with the Purchasers valued at Company obligated to use reasonable best efforts to obtain stockholder approval for exercise of Pre- (effective 2024-04-22).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the Purchasers
- Value
- Company obligated to use reasonable best efforts to obtain stockholder approval for exercise of Pre-
- Effective
- 2024-04-22
Exact text from the filing
In connection with the Private Placement, the Company intends to enter into a Voting Commitment Agreement with the Purchasers on the Closing Date (the “Voting Commitment Agreement”).
View on SEC.gov